Posted September 17, 2019
LoRusso P, Boerner S, Pilot MJ, Forman K, Zuccaro C, Kiefer J, Liang W, Hunsberger S, Redman B, Markovic S, Sekulic A, Bryce A, Joseph R, Cowey CL, Fecher LA, Sosman J, Chapman P, Schwartz G, Craig DW, Carpten JD, and Trent JM. Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non–V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team. Molecular Cancer Therapeutics. 2015 Aug;14(8):1962-71